Phreesia, Inc. 於美國及加拿大為醫療保健行業提供整合式 SaaS 軟件及支付平台。公司總部位於北卡羅來納州羅利。
財務指標
營業收入
2026-07-31
$129.45M
2026-04-30
$130.93M
2026-01-31
$127.06M
2025-10-31
$120.33M
營業支出
2026-07-31
$65.12M
2026-04-30
$70.56M
2026-01-31
$92.23M
2025-10-31
$78.56M
淨利潤
2026-07-31
$1.91M
2026-04-30
$2.96M
2026-01-31
$1.29M
2025-10-31
$4.27M
淨利潤率
2026-07-31
1.48%
2026-04-30
2.26%
2026-01-31
1.01%
2025-10-31
3.54%
每股收益
2026-07-31
$0.03
2026-04-30
$0.19
2026-01-31
$0.44
2025-10-31
$0.31
息稅折舊攤銷前利潤
2026-07-31
$21.04M
2026-04-30
$16.97M
2026-01-31
$5.17M
2025-10-31
$12.92M
有效稅率
2026-07-31
40.78%
2026-04-30
37.26%
2026-01-31
112.54%
2025-10-31
16.66%
項目
2026-07-31
2026-04-30
2026-01-31
2025-10-31
營業收入
$129.45M
$130.93M
$127.06M
$120.33M
營業支出
$65.12M
$70.56M
$92.23M
$78.56M
淨利潤
$1.91M
$2.96M
$1.29M
$4.27M
淨利潤率
1.48%
2.26%
1.01%
3.54%
每股收益
$0.03
$0.19
$0.44
$0.31
息稅折舊攤銷前利潤
$21.04M
$16.97M
$5.17M
$12.92M
有效稅率
40.78%
37.26%
112.54%
16.66%
常見問題
PHR stock represents shares of Phreesia, Inc., a healthcare technology company listed on the New York Stock Exchange. The ticker PHR allows investors to trade ownership units in the company on public markets. Phreesia provides patient intake and engagement software for healthcare providers, aiming to streamline administrative workflows. As a stock, PHR gives shareholders a claim on the company's future earnings and growth prospects within the healthcare IT sector.
Recent performance of PHR stock can be tracked through the price chart and performance metrics displayed on this page. The stock's movement reflects investor reactions to quarterly results, guidance updates, and broader sector trends. For the latest percentage changes over various periods, including daily, weekly, and year-to-date, refer to the live data shown above. This information is updated regularly to provide current performance insights.
Evaluating PHR's valuation involves analyzing metrics such as price-to-sales, price-to-earnings, and enterprise value multiples, which are available on this page. Since Phreesia operates in the healthcare technology sector, comparing these ratios with industry peers can provide context. Additionally, assessing growth rates, profitability, and cash flow trends helps determine whether the current market price aligns with fundamentals. Always consider the company's stage of growth when interpreting valuation multiples.
To buy PHR stock, you need a brokerage account with a platform that offers access to U.S. exchanges. Once your account is funded, you can place a market or limit order for PHR shares during regular trading hours. Many brokerages also allow extended-hours trading and fractional shares, depending on your account type. Confirm any commissions or fees before trading, and review the order types available to match your strategy.
Investors can assess PHR's profitability by examining metrics such as gross margin, operating margin, net income, and free cash flow, all of which are reported in the company's financial statements. These figures indicate how efficiently Phreesia converts revenue into profits. Comparing these margins to historical trends and industry benchmarks helps gauge operational efficiency. Additionally, analyzing customer acquisition costs and retention rates provides insight into sustainable profitability.
Key risks for PHR include intense competition in healthcare technology, reliance on maintaining and expanding client relationships, and potential regulatory changes affecting digital health solutions. The company's growth depends on successful product adoption and integration with healthcare providers. Additionally, macroeconomic factors such as healthcare spending trends and interest rates can influence performance. Investors should review the risk factors disclosed in Phreesia's SEC filings for a comprehensive list.